查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378608

植物来源疫苗市场：按疫苗类型、来源、应用和地区划分

Plant-based Vaccines Market, By Vaccine Type, By Source, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2023 年，全球植物来源疫苗市场价值将达到 9,590 万美元，预计在预测期内（2023-2030 年）年复合成长率为 51.3%。

报告范围 报告详情
基准年 2022年 2023年市场规模 9590万美元
实绩资料 2018-2021 预测期 2023-2030
预测期年复合成长率 51.30% 2030年市场规模预测 17.391 亿美元
图 1. 2023 年植物来源的全球市场占有率(%)，依应用分类
植物疫苗市场-IMG1

疫苗是减轻感染疾病负担最具成本效益和最有效的手段。人们不断寻求新的方法来提高产品品质和可近性，同时降低製造成本。传统上，疫苗使用病原体的弱化版本，或致病生物体或其适当部分（例如毒素）的製备和灭活，并以足够的量给药以诱导免疫。不可避免的可能性是，此类疫苗可能被可感染此类物质的不确定物质污染。一种令人兴奋的新可能性是在基因改造植物中生产疫苗抗原，并使用传统方法提取和精製它们。此类疫苗可以食用或涂布黏膜表面。植物来源有几个优点。它们能够被患者耐受，价格便宜并且可以大量生产，并且所得抗原稳定并且可以长期保存。植物病毒污染不太可能对人类产生任何负面影响。为了使植物来源疫苗广泛使用，必须解决一些技术挑战，并且必须制定此类新型疫苗的法规要求。此外，这项新技术必须被广泛接受。

市场动态

市场主要企业增加产品推出预计将在预测期内推动全球植物来源疫苗市场的成长。例如，2022年12月，化学公司赢创宣布推出植物来源角鲨烯，可提高疫苗的效力。 PhytoSquene 是第一个已知的源自苋菜油的角鲨烯，可用作肠胃外剂型的佐剂。这是为了满足对非动物源角鲨烯的稳定商业性供应的需求。

本研究的主要特点

  • 本报告对全球植物来源市场进行了详细分析，并提出了以2022年为基准年的预测期（2023-2030）的市场规模和复合年度（年复合成长率）。
  • 它还阐明了不同细分市场的潜在收益成长机会，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球植物来源疫苗市场的主要企业。
  • 受调查的主要公司包括 Medicago, Inc.、IBIO, Inc.、Icon Genetics GmbH、Lumen Bioscience, Inc.、英美烟草公司、Creative Biolabs, Inc.、Leaf Expression Systems Ltd. 和 ZYUS Life Sciences Inc. PlantForm Corporation和传染病研究所(IDRI)。
  • 本报告中的见解将帮助行销人员和公司负责人就未来的产品发布、经营团队、市场扩张和行销策略做出资讯的决策。
  • 全球植物来源疫苗市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球植物来源疫苗市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第1章调查目的和假设

  • 这项研究的目的
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第3章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 市场机会
  • 影响分析
  • 最近测试启动
  • 流行病学
  • 合併、收购和合作
  • 法规场景
  • 主要进展
  • PEST分析

第4章全球植物来源疫苗市场 - COVID-19 疾病的影响分析

  • 经济影响
  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 对需求和供给的影响

第5章全球植物来源疫苗市场，依疫苗类型，2018-2030

  • 细菌疫苗
  • 病毒疫苗
  • 寄生虫疫苗
  • 其他的

第6章全球植物来源疫苗市场（依来源），2018-2030 年

  • 烟草草
  • 玉米
  • 马铃薯
  • 其他的

第7章全球植物来源疫苗市场，依应用分类，2018-2030

  • 流感
  • COVID-19
  • 寨卡病毒
  • 伊波拉病毒
  • 家禽疾病
  • 其他的

第8章全球植物来源疫苗市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章竞争形势

  • 公司简介
    • Medicago, Inc
    • IBIO, Inc.
    • Icon Genetics GmbH
    • Lumen Bioscience, Inc
    • British American Tobacco Plc
    • Creative Biolabs, Inc
    • Leaf Expression Systems Ltd
    • ZYUS Life Sciences Inc.,
    • PlantForm Corporation
    • Infectious Disease Research Institute（IDRI）

第10章章

  • 参考
  • 调查方法
简介目录
Product Code: CMI2004

The global plant-based vaccines market is estimated to be valued at US$ 95.9 million in 2023 and is expected to exhibit a CAGR of 51.3% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 95.9 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 51.30% 2030 Value Projection: US$ 1,739.1 Mn
Figure 1. Global Plant-based Vaccines Market Share (%), By Application, 2023
Plant-based Vaccines Market - IMG1

Vaccines are the most cost-effective and efficacious means of reducing the disease burden of infectious diseases. Novel approaches to improve product quality and improve access while lowering production costs are continuously sought. Traditionally, vaccines are prepared by using an attenuated version of the pathogen or by preparing and inactivating a disease-causing organism or a suitable part of it, e.g. a toxin, and administering it in quantities sufficient to induce immunity. Such vaccines have the unavoidable potential for contamination with adventitious agents that can infect such materials. A new and exciting possibility is the production of vaccine antigens in genetically modified plants, which can then be extracted and purified by conventional methods. Such vaccines could either be eaten or applied to mucosal surfaces. Plant-derived vaccines have several advantages. They are easily tolerated by patients, can be made cheaply in very large quantities, and the antigens obtained from them are stable and can be kept in storage for a very long time. The likelihood that contamination by a plant virus would have an adverse effect on humans is almost negligible. There are several technical challenges concerning plant-derived vaccines that must be resolved before they can enter wide-scale use, and the regulatory requirements for this novel class of vaccines must be established. In addition, public acceptance of the new technology must be ensured.

Market Dynamics

Increasing product launches by key players in the market are expected to drive the growth of the global plant-based vaccines market over the forecast period. For instance, in December 2022, Evonik, a chemical company, announced the launch of plant-based squalene to boost vaccine efficacy. PhytoSquene is the first known amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. It meets the demand for a secure commercial supply of non-animal-derived squalene.

Key features of the study:

  • This report provides an in-depth analysis of the global plant-based vaccines market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global plant-based vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Medicago, Inc., IBIO, Inc., Icon Genetics GmbH, Lumen Bioscience, Inc., British American Tobacco Plc., Creative Biolabs, Inc., Leaf Expression Systems Ltd., ZYUS Life Sciences Inc., PlantForm Corporation, and Infectious Disease Research Institute (IDRI).
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global plant-based vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plant-based vaccines market

Global Plant-based Vaccines Market Detailed Segmentation:

  • By Vaccine Type:
    • Bacterial Vaccines
    • Viral Vaccines
    • Parasite Vaccines
    • Others
  • By Source:
    • Tobacco Plant
    • Maize
    • Potato
    • Others
  • By Application:
    • Influenza
    • COVID-19
    • Zika Virus
    • Ebola Virus
    • Poultry Disease
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles
    • Medicago, Inc.
    • IBIO, Inc.
    • Icon Genetics GmbH
    • Lumen Bioscience, Inc.
    • British American Tobacco Plc.
    • Creative Biolabs, Inc.
    • Leaf Expression Systems Ltd.
    • ZYUS Life Sciences Inc.
    • PlantForm Corporation
    • Infectious Disease Research Institute (IDRI)

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Vaccine Type
    • Market Snippet, By Source
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Plant-based Vaccines Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Plant-based Vaccines Market, By Vaccine Type, 2018-2030, (US$ Mn )

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Bacterial Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn )
    • Segment Trends
  • Viral Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
    • Segment Trends
  • Parasite Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
    • Segment Trends

6. Global Plant-based Vaccines Market, By Source, 2018-2030, (US$ Mn )

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Tobacco Plant
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
    • Segment Trends
  • Maize
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
    • Segment Trends
  • Potato
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
    • Segment Trends

7. Global Plant-based Vaccines Market, By Application, 2018-2030, (US$ Mn )

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Influenza
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
  • Covid-19
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
  • Zika Virus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
  • Ebola Virus
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
  • Poultry Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )

8. Global Plant-based Vaccines Market, By Region, 2018-2030, (US$ Mn )

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018-2030, (US$ Mn )
    • Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn )
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn )
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018-2030, (US$ Mn )
    • Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn )
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn )
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018 - 2030, (US$ Mn )
    • Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn )
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn )
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018-2030, (US$ Mn )
    • Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018-2030, (US$ Mn )
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn )
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018-2030, (US$ Mn )
    • Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn )
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn )
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018-2030, (US$ Mn )
    • Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn )
    • Market Size and Forecast, Y-o-Y Growth and By Country/Region, 2018-2030, (US$ Mn )
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • Medicago, Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • IBIO, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Icon Genetics GmbH
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Lumen Bioscience, Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • British American Tobacco Plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Creative Biolabs, Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Leaf Expression Systems Ltd
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • ZYUS Life Sciences Inc.,
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • PlantForm Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Infectious Disease Research Institute (IDRI)
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact